The Severity of Experimental Autoimmune Cystitis Can be Ameliorated by Anti-CXCL10 Ab Treatment

Udai P. Singh; Narendra P. Singh; Honbing Guan; Venkatesh L. Hegde; Robert L. Price; Dennis D. Taub; Manoj K. Mishra; Mitzi Nagarkatti; Prakash S. Nagarkatti

doi:10.1371/journal.pone.0079751

Loading metrics

Open Access

Peer-reviewed

Research Article

The Severity of Experimental Autoimmune Cystitis Can be Ameliorated by Anti-CXCL10 Ab Treatment

Udai P. Singh ,

* E-mail: Udai.singh@uscmed.sc.edu

Affiliation Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
⨯
Narendra P. Singh,

Affiliation Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
⨯
Honbing Guan,

Affiliation Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
⨯
Venkatesh L. Hegde,

Affiliation Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
⨯
Robert L. Price,

Affiliation Department of Cell and Developmental Biology, University of South Carolina, Columbia, South Carolina, United States of America
⨯
Dennis D. Taub,

Affiliation Hematology and Immunology Research, VA Medical Center, Department of Veteran Affairs, Washington DC, United States of America
⨯
Manoj K. Mishra,

Affiliation Department of Math and Sciences, Alabama State University, Montgomery, Alabama, United States of America
⨯
Mitzi Nagarkatti,

Affiliation Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
⨯
Prakash S. Nagarkatti

Affiliation Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
⨯

The Severity of Experimental Autoimmune Cystitis Can be Ameliorated by Anti-CXCL10 Ab Treatment

Udai P. Singh,
Narendra P. Singh,
Honbing Guan,
Venkatesh L. Hegde,
Robert L. Price,
Dennis D. Taub,
Manoj K. Mishra,
Mitzi Nagarkatti,
Prakash S. Nagarkatti

Published: November 21, 2013
https://doi.org/10.1371/journal.pone.0079751

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Bladder
Is the Subject Area "Bladder" applicable to this article?

Thanks for your feedback.
Mast cells
Is the Subject Area "Mast cells" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Neutrophils
Is the Subject Area "Neutrophils" applicable to this article?

Thanks for your feedback.
Cystitis
Is the Subject Area "Cystitis" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.